Grab FM!: Monitoring the marketing of food and beverages to teenagers
Summary
Health Canada has committed to monitor the marketing of unhealthy food and beverages to teenagers as part of its "Healthy Eating Strategy". This study will engage teenagers in the process of monitoring, asking them to identify what counts as teen-oriented food promotion. Teenagers will be provided with a smartphone app called Grab FM! ("Grab Food Marketing!"), which allows them to capture the food and beverage marketing that they feel is targeted specifically to them.
Participating teenagers will be asked to:
1) Use the app to capture images of food and beverage marketing for a period of 7 consecutive days.
2) To complete a survey based on your experience at the end of the 7 day period.
Eligibility
Eligible gender: Male, Female, Transgender, Other
Eligible ages: 13 to 17
Accepts healthy participants: Yes
Inclusion criteria:
a) You are eligible to participate if you are a teenager between the ages of 13 and 17, and currently live in Canada.
b) You must provide (and verify) a school-issued email address to show that you are a current high school student at a Canadian High School.
Exclusion criteria:
You are not eligible to participate if you are under the age of 13, or over the age of 17.
You are not eligible to participate if you cannot provide (and verify) a school-issued email address to show that you are a current high school student at a Canadian High School.
Participate
Fill out the following form if you want to participate in this research
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Additional information
Contact information
Dr. Emily Truman GrabFM! Program Coordinator Communication, Media and Film University of Calgary emily.truman@ucalgary.ca
Principal investigator:
Charlene Elliott
Clinical trial:
No
REB-ID:
REB19-0020